Tom Sack joined Byrne-Pelofsky in 2023 after a 40-year career at MRIGlobal. As President and CEO from 2012 through 2022, he led MRIGlobal’s $115M diverse research portfolio covering projects in health, national security, defense, and energy. In 2019, Tom and his team successfully managed a $15M capital campaign to expand MRIGlobal’s KC presence in life sciences, despite the challenges of the pandemic. That expansion enabled MRIGlobal to provide critical research addressing the development of COVID diagnostics, vaccines, and test protocols, and to configure mobile diagnostic facilities for underserved communities. In 2016, Tom reinvigorated MRIGlobal’s government relations program, which enabled significant growth in US government funding and over $3M in government directed spending.
Tom’s role in executive leadership, combined with decades of experience securing government and commercial projects to address national and global challenges, provides a unique skill set. That expertise includes scientific R&D management, proposal writing, corporate governance, government relations, program management and strategy.
As an advocate for science and education, Tom serves on the Board of Directors of Kansas City’s Union Station, Rockhurst University, and BioNexus KC. and previously on the Executive Advisory Committee for FIRST Robotics, Kansas City Region.
Tom received a Bachelor of Science degree in Chemistry from Rockhurst College, and a Ph.D. in analytical chemistry from the University of Nebraska-Lincoln. Tom is a member of the American Chemical Society and has coauthored more than 50 publications and technical papers.
Email Tom Sack